Glenmark Generics, on Thursday, said that its U.S. subsidiary had filed a lawsuit in the Court of Chancery of the State of Delaware, U.S., to enforce Glenmark's royalty-bearing licence agreement. A statement from Glenmark said that it had an ... The Hindu, 1 month ago
Glenmark files lawsuit in US court for Hydrocortisone Butyrate cream - Myiris, 1 month ago
Glenmark Generics Inc., USA has filed a lawsuit in the Court of Chancery of the State of Delaware - Equity Bulls, 1 month ago
1 images for "glenmark generics inc"
NEW DELHI: Glenmark Pharmaceuticals today said it's US subsidiary has filed a lawsuit in the Court of Chancery of the State of Delaware to enforce it's exclusive royalty-bearing licence agreement. The agreement is with Triax Pharmaceuticals, ...Economic Times, 1 month ago Glenmark Pharma jumps after unit files lawsuit in US Capital Market, 1 month ago Glenmark Generics files law suit to enforce licence pact NDTV Profit, 1 month ago
Philip Andrew Gioia has more than 25 years of experience in the US pharma industry C.H. Unnikrishnan Tweet Tweet 0 Subscribe to: Daily Newsletter Breaking News Latest News 07:49 PM IST 07:45 PM IST 07:38 PM IST 07:35 PM IST ...Livemint.com, 6 days ago Glenmark Announces Appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API Business FierceBiotech, 3 days ago Glenmark appoints Philip Andrew Gioia as president, North America and Global API Business PharmaBiz, 6 days ago
Source: IRIS (10-OCT-13) Comments | Post Comment Glenmark Pharmaceuticals, a manufacturer of generic formulation products and API, climbed on Thursday after its subsidiary, Glenmark (Q,N,C,F)* Generics Inc, USA filed a lawsuit in the court of ...MyIris, 1 month ago Glenmark Pharma climbs as subsidiary files lawsuit in US New Indian Express, 1 month ago Glenmark climbs on US FDA nod for Desoximetasone Myiris, 2 months ago
NEW DELHI: Drugmaker Glenmark Pharmaceuticals has put on the block its oral contraceptive product division which makes the generic anti-pregnancy medicine and sells it in the American market, two persons familiar with the development told ET. The ...Pharmaceutical & Medical Packaging News, 2 months ago Glenmark Pharma To Sell Its Oral Contraceptive Unit Deal Curry, 2 months ago Glenmark Pharma strengthens on plan to sell oral contraceptive product division Arihant Capital, 2 months ago
More from: , Pharmacy Choice...and 2 other sources
The drugmaker has sued the US firms for violating its exclusive right to sell a cheaper version of skincare drug Locoid Lipocream in the US QUICK LINKS: Financial Services | Manufacturing | Retail | Telecom | Infotech QUICK LINKS: Financial ...Livemint.com, 1 month ago
Forest Laboratories, Inc. (NYSE:) and Forest Laboratories Holdings, Ltd. (collectively, "Forest") announced today that they have entered into a settlement agreement with Actavis, Inc. and related companies and subsidiaries thereof, in patent ...OSIX News, 1 month ago FOREST LABORATORIES, INC. : Announces Settlement of BYSTOLIC® Patent Litigation 4 Traders, 1 month ago
- Net Profit for the Second Quarter was Rs 1542.97 Mn as Compared to Rs. 1567.52 Mn for the Previous Corresponding Quarter Highlights: Q2-FY14 - Results - Generics Business Registered Sales Growth of 22.51%. to Rs. 7106.55 Mn in Q2 - US ...PR Newswire India, 1 month ago
Chennai-based Bafna Pharmaceuticals is in talks to be acquired by US-based generic drug maker Mylan and two Indian pharma companies, ET states. The promoters are intending to divest their stake in the company. Founded in 1981, Bafna Pharmaceutical ...Pharmacy Choice, 1 week ago
/PRNewswire/ -- Drug selling in Brazil - this new analysis shows you trends, opportunities, and revenues Do you want to assess the future of pharmaceuticals in Brazil? See what lies ahead, then. Visiongain's new report gives you revenue ...Individual.com, 1 week ago
on your WebpageAdd Widget >Get your members hooked!